Cyclobenzaprine is a muscle relaxant prescribed for short-term relief of muscle spasms caused by acute injuries like back strains, neck pain, or other musculoskeletal problems. It’s one of the most widely studied muscle relaxants available and is typically used alongside rest and physical therapy rather than as a standalone treatment. Most prescriptions are limited to two or three weeks.
How Cyclobenzaprine Works
Unlike pain medications that block pain signals directly, cyclobenzaprine works in the brain and spinal cord to reduce muscle tension at its source. It blocks certain signaling pathways in the brainstem that normally facilitate muscle contraction. Specifically, it interferes with the brain’s ability to send “tighten up” signals down the spinal cord to your muscles, which is why it can ease the cycle of spasm, pain, and more spasm that often follows an injury.
Because it acts on the central nervous system rather than on the muscles themselves, cyclobenzaprine causes drowsiness in most people. Its chemical structure closely resembles older tricyclic antidepressants, which explains both its sedating quality and some of its side effects.
Conditions It Treats
The FDA-approved use is narrow: relief of muscle spasm tied to acute, painful musculoskeletal conditions. In practice, that covers a wide range of everyday injuries. Back strains, whiplash, pulled muscles, and similar problems that cause painful tightening or cramping are the most common reasons it’s prescribed. A meta-analysis of 14 studies found cyclobenzaprine moderately more effective than placebo for back and neck pain over periods of up to two weeks.
One important distinction: cyclobenzaprine does not help with spasticity caused by neurological conditions like cerebral palsy, multiple sclerosis, or spinal cord injuries. These involve a different type of muscle tightness that cyclobenzaprine can’t address.
Off-Label Use for Fibromyalgia
Cyclobenzaprine is sometimes prescribed off-label for fibromyalgia, though it isn’t approved for this purpose. The European Alliance of Associations for Rheumatology has issued a weak recommendation for it based on evidence that it may improve sleep problems associated with fibromyalgia, while noting it hasn’t shown consistent pain improvement after 12 weeks. A newer sublingual (under-the-tongue) formulation taken at bedtime has shown more promising results in a phase 3 trial, significantly reducing widespread pain, sleep disruption, and fatigue compared to placebo. That formulation is designed to deliver higher levels of the drug during sleep hours, then taper off by morning.
What to Expect When Taking It
Cyclobenzaprine comes in two forms. The immediate-release tablet is typically taken three times a day, usually at 5 or 10 mg per dose. The extended-release capsule is taken once daily, starting at 15 mg, with some people increasing to 30 mg. Evidence suggests that the lower 5 mg dose of the immediate-release tablet works about as well as the higher 10 mg dose but causes fewer side effects.
Drowsiness is by far the most common side effect. In clinical trials, sleepiness increased by nearly 20% at higher doses compared to lower ones. Dry mouth and dizziness are also frequently reported. Because of the sedation, many people find it helpful to take the medication at bedtime, especially if muscle spasms are disrupting sleep. The sedating properties can actually be a benefit in that situation.
Treatment is meant to be short. The FDA recommends no more than two to three weeks of use because the muscle spasms it targets typically resolve in that window, and there’s no good evidence that longer courses help.
How It Compares to Other Muscle Relaxants
Head-to-head studies have not found any single muscle relaxant to be clearly superior to the others. Cyclobenzaprine, however, has the largest body of evidence behind it, with consistently proven effectiveness for pain, spasm, and overall function. Studies comparing it to other common options found no meaningful differences in outcomes.
The main trade-off is sedation. Cyclobenzaprine is on the more sedating end of the spectrum. If drowsiness is a significant concern, particularly for people who need to stay alert during the day, other options may cause less sedation, though the evidence supporting their effectiveness is more limited.
Side Effects and Risks
Beyond drowsiness and dry mouth, cyclobenzaprine can cause a rapid heart rate. A five-year review of cyclobenzaprine toxicity cases found lethargy in 54% of cases and rapid heart rate in 33%. At normal prescribed doses, these effects are usually mild, but they illustrate why taking more than directed is risky.
The more serious concerns involve drug interactions and certain pre-existing conditions. Cyclobenzaprine should not be taken by people with:
- Heart conditions including irregular heartbeat, heart block, congestive heart failure, or anyone in the early recovery phase after a heart attack
- Overactive thyroid (hyperthyroidism)
- Current or recent use of MAO inhibitors, a class of antidepressant. There must be at least a 14-day gap between stopping an MAO inhibitor and starting cyclobenzaprine. Combining them has caused dangerously high fevers, seizures, and deaths
Because cyclobenzaprine affects some of the same brain chemistry as antidepressants, combining it with SSRIs, SNRIs, or other medications that raise serotonin levels can increase the risk of serotonin syndrome, a potentially dangerous condition involving agitation, rapid heartbeat, high body temperature, and muscle rigidity. If you take an antidepressant, this is worth discussing before starting cyclobenzaprine.
Alcohol and other sedating medications amplify the drowsiness cyclobenzaprine already causes, making the combination particularly hazardous for driving or operating machinery.
Why It’s a Short-Term Medication
The two-to-three-week limit exists for two reasons. First, the injuries that cause acute muscle spasm generally improve within that timeframe on their own, especially with rest and physical therapy. Second, there simply isn’t evidence that cyclobenzaprine continues to provide benefit beyond a few weeks. If your pain and spasms persist past that window, it typically signals a need to re-evaluate the underlying problem rather than continue the same medication.